Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.
Information source: University of Oslo
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Magnetic Resonance Imaging, Intestine Small, Crohn Disease.
Intervention: MRI of the small bowel (Procedure)
Phase: Phase 3
Status: Active, not recruiting
Sponsored by: University of Oslo Official(s) and/or principal investigator(s): Nils-Einar Kløw, Prof. MD, Study Director, Affiliation: Ulleval Universitetssykehus
Summary
The purpose of this study is to compare MRI enteroclysis with MRI of the small bowel with a
per oral 6%mannitol solution. Our hypothesis is that the peroral technique preform the same
way as MRI Enteroclysis.
Clinical Details
Official title: MRI of the Small Bowel. Comparison of Different Techniques and Contrast.
Study design: Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- above 18 years
- known Crohns disease or strong suspicion.
- need of a small bowel examination
Exclusion Criteria:
- pregnant
- electrolyte disturbances.
- Any MRI contraindications.
Locations and Contacts
Ulleval Universitets sykehus, Kirkeveien 166, Oslo 0407, Norway
Additional Information
Starting date: November 2004
Last updated: September 7, 2006
|